{"DataElement":{"publicId":"2635488","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Involvement Maximum Grade","preferredDefinition":"the maximum grade or stage of severity of acute graft versus host disease, a syndrome of immunologically mediated tissue damage occurring following allogeneic transplant affecting the lower gastrointestinal tract, the esophagus, stomach, and duodenum, with onset is usually within one hundred days of transplantation or immunologic manipulation.","longName":"AGVHD_U_GI_INV_M_GD","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2635437","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Involvement","preferredDefinition":"information related to the acute graft versus host disease, a syndrome of immologically mediated tissue damage occurring following allogeneic transplant affecting the lower gastrointestinal tract, the esophagus, stomach, and duodenum, with onset is usually within one hundred days of transplantation or immunologic manipulation.","longName":"AGVHD_U_GI_INVLT","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512823","version":"1","preferredName":"Acute Graft Versus Host Disease","preferredDefinition":"A graft versus host disease with symptoms appearing within the first 100 days post-transplant, but with short duration.","longName":"C4980","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898438-B0B8-35BB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2635435","version":"1","preferredName":"Upper Gastrointestinal Tract Involvement","preferredDefinition":"Upper; higher in place or position; the topmost one of two.:Definition not available.:To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25355:C34082:C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper","conceptCode":"C25355","definition":"Higher in place or position; the topmost one of two.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gastrointestinal Tract","conceptCode":"C34082","definition":"The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F80250E-39B9-629E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F802BAE-F620-630A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2635474","version":"1","preferredName":"Acute Graft Versus Host Disease Upper Gastrointestinal Tract Maximum Grade","preferredDefinition":"The largest possible scale of intensity of acute graft versus host disease involving the upper gastrointestinal tract.","longName":"AGVHD_U_GI_MAX_GD","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"9","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":"No protracted nausea or vomiting","ValueMeaning":{"publicId":"2635489","version":"1","preferredName":"No protracted nausea or vomiting","longName":"2635489","preferredDefinition":"No protracted nausea or vomiting","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F808CE4-E227-0624-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F80CACA-F131-0619-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Persistent nausea, vomiting, or anorexia","ValueMeaning":{"publicId":"2635490","version":"1","preferredName":"Persistent nausea, vomiting, or anorexia","longName":"2635490","preferredDefinition":"Persistent nausea, vomiting, or anorexia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F80CACA-F11A-0619-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2F80CACA-F143-0619-E044-0003BA3F9857","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2635467","version":"1","preferredName":"Maximum Grade","preferredDefinition":"the largest possible quantity or degree.:A position on a scale of intensity or amount or quality.","longName":"C25564:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maximum","conceptCode":"C25564","definition":"The largest possible quantity or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F7FEB1F-64AC-7116-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"ONEDATA","dateModified":"2007-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F813B97-CC97-03CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Maximum Stage of GVHD of the","type":"Preferred Question Text","description":"Maximum Stage of GVHD of the Upper GI Tract","url":null,"context":"NHLBI"},{"name":"CRF Text","type":"Alternate Question Text","description":"Upper GI Abnormality","url":null,"context":"NHLBI"}],"origin":"Transplant CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F8170E5-693F-0620-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-02","modifiedBy":"KUMMEROA","dateModified":"2021-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}